Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Endoscopically implantable devices into submucosa as the solution for low-gravity induced gastrointestinal problems

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F17%3A43916988" target="_blank" >RIV/00216208:11120/17:43916988 - isvavai.cz</a>

  • Výsledek na webu

  • DOI - Digital Object Identifier

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Endoscopically implantable devices into submucosa as the solution for low-gravity induced gastrointestinal problems

  • Popis výsledku v původním jazyce

    The future manned space missions will be challenging not only from technical point of view but medical as well. Although the process of selecting suitable candidates is rigorous, medical complications can still occur during longterm space flight. Gastrointestinal problems are a quite significant group of all medical events among astronauts. One of the main gastrointestinal problems is the gastroesophageal reflux disease (GERD). The gravity normally keeps the acid reflux from developing. However, in low gravity or microgravity, the acid can press against lower esophageal sphincter easier which may lead to GERD. We developed a method to address these challenges with a battery-less endoscopically implantable device. A miniature implantable capsule (14 mm x 14 mm x 6 mm) was designed to assess the technology. It is powered wirelessly using inductive coupling with the transmitter coil and features two-lead bipolar electrical stimulation. The experiments were performed in an animal model and living animals. The device was endoscopically implanted into submucosal space near lower esophageal sphincter. The device stimulates the muscularis propria inside esophagus to prevent GERD. Minimal invasiveness and virtually no bleeding during surgery when compared to today&apos;s solutions for neurostimulation make the presented solution a novel approach which could be carried out in space or before space flight without the need for full anaesthesia. Future work will be focused on implementing different types of sensors and actuators to treat different gastrointestinal diseases which could occur during long-term spaceflight.

  • Název v anglickém jazyce

    Endoscopically implantable devices into submucosa as the solution for low-gravity induced gastrointestinal problems

  • Popis výsledku anglicky

    The future manned space missions will be challenging not only from technical point of view but medical as well. Although the process of selecting suitable candidates is rigorous, medical complications can still occur during longterm space flight. Gastrointestinal problems are a quite significant group of all medical events among astronauts. One of the main gastrointestinal problems is the gastroesophageal reflux disease (GERD). The gravity normally keeps the acid reflux from developing. However, in low gravity or microgravity, the acid can press against lower esophageal sphincter easier which may lead to GERD. We developed a method to address these challenges with a battery-less endoscopically implantable device. A miniature implantable capsule (14 mm x 14 mm x 6 mm) was designed to assess the technology. It is powered wirelessly using inductive coupling with the transmitter coil and features two-lead bipolar electrical stimulation. The experiments were performed in an animal model and living animals. The device was endoscopically implanted into submucosal space near lower esophageal sphincter. The device stimulates the muscularis propria inside esophagus to prevent GERD. Minimal invasiveness and virtually no bleeding during surgery when compared to today&apos;s solutions for neurostimulation make the presented solution a novel approach which could be carried out in space or before space flight without the need for full anaesthesia. Future work will be focused on implementing different types of sensors and actuators to treat different gastrointestinal diseases which could occur during long-term spaceflight.

Klasifikace

  • Druh

    D - Stať ve sborníku

  • CEP obor

  • OECD FORD obor

    30219 - Gastroenterology and hepatology

Návaznosti výsledku

  • Projekt

  • Návaznosti

    S - Specificky vyzkum na vysokych skolach

Ostatní

  • Rok uplatnění

    2017

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název statě ve sborníku

    Proceedings of the International Astronautical Congress; Vol. 3

  • ISBN

    978-1-5108-5537-3

  • ISSN

  • e-ISSN

    neuvedeno

  • Počet stran výsledku

    4

  • Strana od-do

    1961-1964

  • Název nakladatele

    International Astronautical Federation

  • Místo vydání

    Paris

  • Místo konání akce

    Adelaide, Australia

  • Datum konání akce

    25. 9. 2017

  • Typ akce podle státní příslušnosti

    WRD - Celosvětová akce

  • Kód UT WoS článku